Darkside of Medicine
Teratogenic Medication
Teratogenic medicines are drugs that can cause harm to a developing baby during pregnancy. These medicines have the potential to interfere with normal growth and development before birth, and their use requires clear communication, strong safeguards, and informed decision‑making.
While many medicines are safe during pregnancy, many are medically necessary; those known to carry teratogenic risks must only be prescribed when no safer alternative exists and when patients are fully informed.
How Teratogenic Medicines Can Affect Pregnancy
Key Risks
Exposure to teratogenic medicines during pregnancy can increase the likelihood of:
-
Birth defects (e.g., heart abnormalities, cleft palate, limb differences)
-
Growth restrictions (babies smaller than expected)
-
Neurodevelopmental conditions (learning difficulties, autism, ADHD)
-
Pregnancy complications, including miscarriage or stillbirth
The understanding of the effects of teratogens is still growing; it is important to talk to your doctor about your medication if you are planning to become pregnant.
For a comprehensive list of teratogenic medicines, visit the website of UKTIS https://uktis.org
Why Awareness Matters
Advocacy Spotlight
Too many women and families are still not given clear, accessible information about the risks of teratogenic medicines.
Raising awareness ensures that:
-
Women and families can make fully informed decisions
-
Healthcare professionals consider safer alternatives
-
Society recognises the long‑term impact of avoidable harm
Awareness is not only a clinical issue, but it is also a matter of patient rights, transparency, and justice.
Protecting Future Generations
Preventing avoidable harm requires:
-
Stronger safety measures and prescribing safeguards
-
Better education for healthcare professionals
-
Full transparency for patients
-
Support for families already affected
By sharing accurate information and advocating for safer practices, we can help protect future generations and ensure that no family faces preventable harm.
📢 Call to Action: Stand With Us to Prevent Avoidable Harm
Every family deserves clear information, safe treatment, and protection from preventable risks.
Your voice can help drive change.
-
Mandatory, consistent communication of teratogenic risks
-
Stronger pregnancy‑prevention programmes
-
Improved training for healthcare professionals
-
National support services for affected families
-
Greater accountability and transparency across the healthcare system
Tne Risks of Polypharmacy and Polytherapy
Every medicine has its own potential side effects or adverse reactions, and each is prescribed for a specific reason. When multiple medicines are taken together, they interact within the body, taking into account the body's own health care needs, fitness level, and age, in highly individual ways. Over time, the body may adapt to a medicine, reducing its effectiveness or increasing unwanted effects, leading to changes in treatment. At the same time, new medicines
are continually being developed, repurposed, and prescribing guidance evolves. Clinicians must work within an ever-expanding and changing knowledge base. Within this complex system, patients also play an important role in their own well-being, particularly through reporting side effects, changes in symptoms, and treatment concerns.A 2012 study commissioned by the GMC and conducted in general practice aimed to determine the prevalence and nature of prescribing errors. It showed that 1 in 20 prescription items has an error and 1 in 550 potentially has a serious outcome
The prescribing cascade happens when a drug’s side effect is wrongly seen as a new illness, prompting the prescription of another drug. This can put the person at risk for further adverse effects from unnecessary medications. Identifying and stopping these cascades is a key step in improving medication safety, especially for older adults.